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The purpose of this study was to evaluate the in vitro cell biocompatibility of an in situ forming composite consisting of chitosan
(CS), nano-hydroxyapatite and collagen (nHAC), which has a complex hierarchical structure similar to natural bone. MC3T3-
E1 mouse calvarial preosteoblasts were cultured on the surface of the injectable CS/nHAC and CS scaﬀold. The proliferations
of seeded MC3T3-E1 were investigated for 10 days. Cytotoxicity, cell proliferation, and cell expression of osteogenic markers
such as alkaline phosphatase (ALP), type 1 collagen (COL-1), RUNX-2, and osteocalcin (OCN) were examined by biochemical
assay and reverse transcription polymerase chain reaction. Cell viability and total cellularity (measured by dsDNA) were similar
betweenthetwoscaﬀoldgroups.However,ALP,COL-1,OCN,andRUNX-2productionweresigniﬁcantlygreaterwhenosteoblasts
were cultured on CS/nHAC scaﬀolds. The increase in osteogenic markers production on CS/nHAC scaﬀolds indicated that these
scaﬀolds were superior to chitosan-only scaﬀolds in facilitating osteoblast mineralization. These results demonstrate the potential
of the CS/nHAC scaﬀolds to be used in bone tissue engineering.
1.Introduction
Annually, more than 2.2 million bone grafting procedures
(autologous bone graft and banked bone) are performed
worldwide to ensure adequate bone healing in many skeletal
problems, such as nonunion fractures, cervical and lumbar
spine fusion, joint arthrodesis, and revision arthroplasty
[1]. Tissue engineering oﬀers a strategy to circumvent
those problems. The concept involves the use of a porous
and biodegradable scaﬀold, allowing cells to adhere and
proliferate, creating conditions for the formation of ECM-
like structures [2–4]. Previous studies have shown that
natural-based polymers such as chitosan [5–10]h a v eg r e a t
potential for bone tissue engineering applications. The main
advantages of these materials include low immunogenic
potential, bioactive behavior, good interaction with host
tissues, chemical versatility, and high availability in nature.
Chitosan is a promising material for bone regeneration
because it is biocompatible and biodegradable with a degra-
dation rate that is dependent on factors such as degree of
deacetylation (DDA) and crystallinity, and it can be easily
formed into beads, ﬁbers, or more complex structures [5, 11,
12].
Bone tissues are mainly constructed from nanosized
hydroxyapatite (HA) minerals and type 1 collagen (Col-
1) matrix with complex hierarchically assembled struc-
tures [13–16]. The ideal scaﬀolds for bone regeneration
should promote early mineralization and support new bone
formation [17–19]. Mineralized collagen ﬁbrils (nHAC)
composites seem to be very promising biomaterials for bone
regeneration [20–23]. In the previouse study, the feasibility
of developing a thermosensitive and injectable chitosan2 Journal of Nanomaterials
solution in the presence of nHAC was demonstrated [23–
25]. Combining nHAC and chitosan has the potential to
maximize the beneﬁcial properties of each and creates an
injectable scaﬀold with properties similar to physiological
bone which would undoubtedly aid in the formation of new
bone at the tissue/biomaterial interface [24–27].
In the present study, the cytocompatibility of the
injectable CS/nHAC scaﬀolds to act as a bone substitude and
its potential for bone tissue engineering were investigated
in vitro. The ability of the injectable CS/nHAC scaﬀolds to
maintaintheviabilityandfunctionalityofseededMC3T3-E1
preosteoblasts was investigated in terms of their proliferation
and osteoblastic diﬀerentiation over 10 days of culture.
2.MaterialsandMethods
2.1. Scaﬀold Processing. The CS/nHAC composite was pre-
pared by the procedure reported previously [24–27]. nHAC
powder was synthesized by self-assembly of nanoﬁbrils of
mineralized collagen and sterilized by γ-ray irradiation (1.5
Mrad). Chitosan (2g) was dissolved in hydrochloric acid
solution (98mL, 0.1M). The nHAC powder was added to
the chitosan solution (0.02g/mL). Finally, the pH of the
CS/nHAC solution was adjusted to 7.0 by adding droplets
of β-glycerophosphate solution (30% (w/v)). The samples
for biological tests were prepared in line with the aseptic
techniqueinanasepticmanipulationcabinet.Solutionswere
injected into a circular mold (12mm diameter and 2mm
thickness) and solidiﬁed in an incubator at 37◦Cf o r1 0m i n
to form a hydrogel scaﬀold.
The CS was prepared similar to the procedure of
CS/nHAC. Chitosan (2g) was dissolved in hydrochloric acid
solution (98mL, 0.1M), and then the pH of the CS solution
was adjusted to 7.0 by adding droplets of β-glycerophosphate
solution (30% (w/v)). The samples for biological tests were
prepared in line with the aseptic technique in an aseptic
manipulation cabinet.
2.2. Cell Culture Studies. MC3T3-E1 murine calvarial
osteoblasts (subclone 14) cells were purchased from the
cell bank of the Chinese Academy of Sciences (Shanghai,
China). The cells were grown in a culture medium consisting
of α-MEM (Sigma, St. Louis, MO), 10% fetal bovine
serum (Biochrom AG, Germany), and 1% of antibiotic-
antimycotic mixture (Sigma, St. Louis, MO) at 37.8◦Ci n
a humidiﬁed atmosphere of 5% CO2.W h e na na d e q u a t e
cell number was obtained, cells at passage 2 were detached
with trypsin/EDTA. Cells were seeded at a density of 2 ×
104 cells/scaﬀold under static conditions, by means of a cell
suspension. The culture medium was changed every 2-3 days
until the end of the experiment.
2.3. In Vitro Cytotoxicity Tests. AC e l lC o u n tK i t - 8( C e l l
Count Kit-8, Beyotime, China) was employed in this
experiment to quantitatively evaluate the cytotoxicity of the
scaﬀold. Cell viability was assessed after MC3T3-E1 were
inoculated on the samples 24-well disks using the CCK-8
kit after 1, 3, 7 and 10 days. CCK-8 reagent (100μL) was
added to MC3T3 in 1mL medium per well. The plates
were incubated at 37◦C for 4h and shaken for 1min. After
this, 200μL( n = 5) were transferred to 96-well plates and
the optical density (OD) was measured on a microplate
reader (BioTek, USA) using an absorbance of 490nm. All the
procedures were replicated 3 times.
2.4. Cell Proliferation by DNA Quantiﬁcation. MC3T3 pro-
liferation on the CS/nHAC scaﬀolds was determined using
a ﬂuorimetric dsDNA quantiﬁcation kit (PicoGreen, Molec-
ular Probes, Invitrogen, USA). Samples collected at days 1,
3, 7, and 10 were washed twice with a sterile phosphate-
buﬀered saline solution and transferred into 1.5mL micro-
tubes containing 1mL of ultrapure water. Cell constructs
were cryopreserved at −80◦C for further analysis. Prior to
DNA quantiﬁcation, samples were thawed and sonicated
for 15min. Standards were prepared with concentrations
ranging between 0 and 2mg/mL. Per each well of an opaque
96-well plate were added 28.7μLo fs a m p l e( n = 3) or
standard, 71.3μL of PicoGreen solution, and 100μLo fT r i s -
EDTA buﬀer. The plate was incubated for 10min in the
dark and ﬂuorescence was measured using an excitation
wavelength of 260nm and an emission wavelength of
280nm. All the procedures were replicated 3 times.
2.5. Alkaline Phosphatase Quantiﬁcation. After culturing
f o r1 ,3 ,7 ,a n d1 0d a y s ,t h ec e l l sw e r ew a s h e da n d
lysed in 0.1vol% Triton X-100. The alkaline phosphatase
(ALP) activity in the lysis was determined through a
p-nitrophenyl phosphate (pNPP) liquid substrate system
(Nanjing Jiancheng, China). Five milliliters of each cell
lysate solution was added to 195μL of pNPP substrate and
incubated in the dark at room temperature for 1min. The
absorbancewasreadusingaplatereader(MolecularDevices,
USA) at 405nm. The intracellular total protein content was
determined using a Micro BCA Protein Assay Kit (Nanjing
Kaiji, China) and the ALP activity was normalized to it.
2.6. Osteogenic Diﬀerentiation by Reverse Transcriptase PCR.
The expression levels of osteogenesis-related genes were
measured using the quantitative reverse transcription-
polymerase chain reaction (qRT-PCR). The cells were seeded
at a density of 2 × 104 cells/well, cultured for 1, 3, 7
and 10 days, and then harvested using TRIzol (Gibco) to
e x t r a c tR N A .A ne q u i v a l e n ta m o u n to fR N Af r o me a c h
sample was reverse-transcribed into complementary DNA
(cDNA) using the Superscript II ﬁrst-strand cDNA synthesis
kit (Invitrogen). The qRT-PCR analysis of genes including
type 1 collagen (COL-1), osteocalcin (OCN), Runt-related
transcription factor 2 (RUNX-2), and 18S ribosomal RNA
(18s rRNA) was performed on the Applied Biosystems 7500
using the Quantitect Sybr Green Kit (Qiagen). The primers
for the target genes were listed in Table 1.T h eC tv a l u e so f
target genes were normalized by the Ct values of the TaqManJournal of Nanomaterials 3
Table 1: Primer sequences and product size for real-time PCR
reactions.
Target Sense and anti-sense sequences bp
OCN 5  AGGGCAATAAGGTAGTGAA
5  CGTAGATGCGTCTGTAGGC 159
RUNX-2 5  TGCCCAGTGAGTAACAGAAAGAC
5  CTCCTCCCTTCTCAACCTCTAA 123
COLL 5  CTTCACCTACAGCACCCTTGT
5  AAGGGAGCCACATCGATGAT 120
18s rRNA 5  CCTGGATACCGCAGCTAGGA
5  GCGGCGCAATACGAATGCCCC 112
human housekeeping gene 18s rRNA to obtain the DCt
values. These values were then subtracted by the Ct value
of the cells cultured on the blank disks to obtain the DDCt
values. The fold of change was obtained with n = 3.
2.7. Statistical Analysis. Statistical signiﬁcance of diﬀerences
was determined using one-way and two-way analysis of
variance ANOVA. If diﬀerences were detected, pairwise com-
parisons were made using Tukey’s HSD test at a conﬁdence
interval of 95% (P<0.05).
3. Result andDiscussion
3.1. In Vitro Cytotoxicity Tests. T h ev i a b l ec e l ld e n s i t y
increasesoverinitialdaysuptoaplateaubasedontheCCK-8
assay (Figure 1). The experimental group and control group
share similar trend of viable cell density over 10 days. the
CS/nHAC group reach a maximum value at day 10, and the
CS group reach a maximum value at day 7; no signiﬁcant
growthdiﬀerence was observed between the two groups after
10 days of incubation (n = 5, P>0.05). The results of the
CCK-8 assay reﬂect an overall activity which is aﬀected by
both cellproliferationandcellviability. Thecellproliferation
assay showed that cells grew normally with the scaﬀolds and
these scaﬀolds were nontoxic for MC3T3-E1.
3.2. Cell Proliferation by DNA Quantiﬁcation. Over the 10
days of the study, the number of cells, as measured by
dsDNA, was essentially equivalent between both CS and
CS/nHAC scaﬀold groups (Figure 2). Overall, there was not
a signiﬁcant amount of cell proliferation detected over the
course of the study. In vitro cell testing of biomaterials is a
well-established method to determine the cytocompatibility
of the materials [27–29] by using either cell lines or primary
cells. This study was designed primarily to analyze the ability
of the composite scaﬀold to support osteoblast matrix pro-
duction, and maintaining similar cell numbers in each group
alloweddiﬀerencesintheseparameterstobestudiedwithout
the confounding eﬀects of cell number diﬀerences. The DNA
concentrationresultofthetwogroupsshowedasimilartrend
to the CCK-8 result. These results demonstrated that both
the CS and CS/nHAC scaﬀold had good cytocompatibility
and MC3T3-E1 viability, so it highlights the application of
CS/nHAC to be a biomaterial for bone tissue engineering.
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Figure 1: CCK-8 assays of MC3T3-E1 proliferation on experimen-
tal group and control group after 1, 3, 7, and 10 days of incubation.
The values are shown as mean±standard deviation (n = 5).
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Figure 2: DNA concentration of MC3T3-E1 proliferation on
experimental group and control group after 1, 3, 7, and 10 days
of incubation. The values are shown as mean±standard deviation
(n = 5).
3.3. Alkaline Phosphatase Quantiﬁcation. ALP activity and
calcium mineralization are mostly used as markers for
early and late diﬀerentiation of osteoblast cells, respectively
[21, 22]. Osteoblastic cell diﬀerentiation was assessed by
measuring ALP activity normalized to total protein content
a f t e r1 ,3 ,7 ,a n d1 0d a y so fc u l t u r e .Figure 3 shows the4 Journal of Nanomaterials
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Figure 3: ALP assays of MC3T3-E1 proliferation on experimental
groupandcontrolgroupafter1,3,7,and10daysofincubation.The
values are shown as mean±standard deviation (n = 3). Bars with
dissimilar letters indicate signiﬁcantly diﬀerent values (∗∗P<0.01).
evolution of ALP activity for MC3T3-E1 cells cultured on
the CS/nHAC surfaces in comparison with CS. The ALP
activity of MC3T3-E1 cells grown on both groups was not
signiﬁcantly diﬀerent for day 1 and 3. However, MC3T3-E1
cells cultured on CS/nHAC scaﬀold had signiﬁcantly higher
ALP activity than those cultured on CS group on day 7 and
10(P<0.001).TheALPactivityofCS/nHACgroupreaching
a top on day 7 was observed. The following decrease on day
10 is likely due to reaching an advanced cell culture stage.
ALP activity is mostly used as markers for early and late
diﬀerentiation of osteoblast cells, respectively [30, 31]. These
results indicate that the CS/nHAC scaﬀold can stimulate
matrix formation and enhance osteoblast cell diﬀerentiation.
3.4. Osteogenic Diﬀerentiation by Reverse Transcriptase PCR.
A semiquantitative RT-PCR method was used to assess gene
expression of osteoblasts after 1, 3, 7, and 10 days. In
order to know whether primary osteoblast diﬀerentiation
was aﬀected by nano-hydroxyapatite/collegen, we selected
COL-1, OCN, and RUNX-2 as markers for osteoblastic
diﬀerentiation in this study. Among bone matrices, COL-1 is
the most abundant protein synthesized by active osteoblasts
andconductivetomineraldeposition.Osteocalcinissecreted
solely by osteoblasts and thought to play a role in the body’s
metabolic regulation and is proosteoblastic or bone-building
[28]. It is also involved in bone mineralization and calcium
ion homeostasis. RUNX-2 gene is a member of the RUNX
family of transcription factors and encodes a nuclear protein
with a Runt DNA-binding domain. The protein can bind
DN Abothasamonomerand,withmoreaﬃnity,asasubunit
ofaheterodimericcomplex.Thisproteinhasbeenimplicated
as a key transcription factor associated with osteoblast
diﬀerentiation [29]. The results of real-time PCR for mRNA
expression of osteocalcin and RUNX-2, both of which
are osteoblast markers, are represented as fold increases.
As shown in Figures 4(a) and 4(b), there are signiﬁcant
diﬀerences in the osteocalcin expression between CS/nHAC
and CS at day 1, 7, and 10 (P<0.001) (Figure 4(a)). The
osteocalcin expression was 5.5-fold higher on day 7 and 2.7-
fold higher on day 10 for the CS/nHAC as opposed to the
CS. Also, the RUNX-2 expression was signiﬁcantly higher by
day 7 and 10 for the CS/nHAC as opposed to the CS group.
The COL-1 expression was signiﬁcantly lower by day 1 and
3 for the CS/nHAC as opposed to the CS group. However,
signiﬁcant higher COL-1 expression of CS/nHAC than CS
was observed at day 7 and 10 (P<0.01).
Due to the current results in vitro, better osteoblasts
viability,anddiﬀerentiationmarkedbyhigherOCN,RUNX-
2 and COL-1 expression were observed on CS/nHAC
surfaces. The addition of nHAC to the chitosan did lead
to signiﬁcantly enhanced osteoblasts diﬀerentiation. There
are several factors that could contribute to the enhanced
mineralized matrix production seen when osteoblasts were
cultured on CS/nHAC scaﬀolds. When calcium phosphate-
containing materials are hydrated in cell culture media, a
continuousprocessofcalciumandphosphateiondissolution
and reprecipitation occurs. This creates a dense carbonated
apatite layer on the surface of the scaﬀold that is similar to
the structure of native bone and may therefore induce more
rapid osteoblast diﬀerentiation and mineralization [30–
32]. Taken together, these gene expression data associated
with the osteoblast phenotype provides evidence that the
scaﬀold constitutes a good substrate for MC3T3-E1 cell
diﬀerentiation leading to ECM mineralization.
4. Conclusions
In this study, we conclude that the CS/nHAC scaﬀold has a
suitablebiocompatibilityforitsuseascellculturescaﬀoldfor
hard tissue regeneration. In vitro experiments revealed more
prominent activation of osteoblast diﬀerentiation in cells
grown on CS/nHAC than in those grown on CS. Collectively,
these data indicates the CS/nHAC may give greater results
concerning cell proliferation and diﬀerentiation compared
to chitosan in this in vitro study. We suggest an excellent
applicability of the CS/nHAC as bone substitutes.
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